Melt Pharmaceuticals, Inc. (MELT)

Melt Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6.18	11.26	2.93
Cash & Cash Equivalents	6.18	11.26	2.93
Cash Growth	-	283.93%	-
Other Current Assets	0.02	0.02	0.02
Total Current Assets	6.2	11.28	2.96
Property, Plant & Equipment	-	-	0
Total Long-Term Assets	-	0	0
Total Assets	-	11.28	2.96
Accounts Payable	-	1.32	1.24
Current Debt	-	14.05	-
Other Current Liabilities	17.64	0.36	0.09
Total Current Liabilities	17.64	15.73	1.34
Other Long-Term Liabilities	-	0.22	0.22
Total Long-Term Liabilities	-	0.22	0.22
Total Liabilities	-	15.95	1.56
Total Debt	15.09	14.05	0
Retained Earnings	-	-16.22	-9.57
Shareholders' Equity	-21.03	-15.01	-8.94
Net Cash / Debt	-8.91	-2.79	2.93
Working Capital	-11.44	-4.45	1.62

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).